In this study, we discovered that gM can inhibit the β-adrenergic receptor signaling pathway and augment DC function, thereby potentiating the antitumor immune response elicited by cancer vaccines and ultimately suppressing tumor progression. The gene discussed is PPP1R3A; the disease is cancer.